N-(Azetidin-3-yl)-2,2,2-trifluoroacetamide hydrochloride, 97%, 1g

Tasimelteon>98.0%(HPLC)50mg

2,6-Dichlorobenzoic acid, 98.0%, 1g

Niflumic Acid, 95%, 1g

5-Chloro-2-(chloromethyl)pyridine hydrochloride, 95.0%, 5g

Ethyl 2-(((1R,2S)-2-hydroxy-1,2-diphenylethyl)amino)acetate, 95.0%, 1g

methyl 3-{[2-(4-methoxyphenyl)ethyl]amino}-2-methylpropanoate, 95.0%, 2g

(4-(Methylsulfonyl)-2-(trifluoromethyl)phenyl)boronic acid, 95.0%, 1g

2-BROMO-6-CHLORONAPHTHALENE, 95.0%, 25g

5-Chloro-4-(trifluoromethyl)pyridin-2-amine hydrochloride, 95.0%, 1g

3-(5-Fluoro-2-methylphenyl)-1-propene, 97.0%, 1g

(4S,4'S)-2,2'-(1-phenylpropane-2,2-diyl)bis(4-benzyl-4,5-dihydrooxazole), 97%, 1g

BENZYL 5-(AMINOMETHYL)-2-METHYLPIPERIDINE-1-CARBOXYLATE HCL, 95.0%, 100mg